Last reviewed · How we verify
NCT04599322
Stabilometry Changes After Dry Needling in Flexor Digitoum Brevis
NA trial testing Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle in Healthy in 18 participants. Completed in 16 November 2020.
9 November 2020
Quick facts
| Lead sponsor | Mayuben Private Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 9 November 2020 |
| Primary completion | 9 November 2020 |
| Estimated completion | 16 November 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle
Conditions studied
- Healthy — all drugs for Healthy →
- Foot — all drugs for Foot →
- Dry Needling — all drugs for Dry Needling →
Sponsor
Mayuben Private Clinic
Who can join
Adults 18 to 40, any sex, with Healthy or Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this clinical trial is to check the balance effects of dry needling in the Flexor digitorum Brevis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04599322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle
Trials testing the same drug.
- NCT05875415 — Dynamic Plantar Pressures Changes After Dry Needling in Flexor Digitorum Brevis Versus Non Emission Laser · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Mayuben Private Clinic trials
Trials by the same sponsor.
- NCT06715904 — Sex Differences in Morton's Extension Application on Plantar Pressure Distribution in Different Foot Regions in Female a · NA · completed
- NCT06514404 — Comparative Study of Empathy and Anxiety in the Different Academic Years, at the Beginning of Academic Year and Exam Per · not yet recruiting
- NCT06526715 — Balance Effects of Morton´s Extension in Flat Foot · NA · completed
- NCT06499545 — Plantar Pressures After Pressure Release of the Flexor Digitorum Brevis Muscle Versus a Non-emission Laser. · NA · completed
- NCT06499493 — Effects of Myofascial Induction Pressure Pain Threshold in Trigger Points of the Proximal Muscles of Gastrocnemius · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04599322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayuben Private Clinic
- Last refreshed: 18 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04599322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing